Healthcare provider profile · identity verified

Binh Khac Le, M.D.

Family Practice · MODESTO, CA · NPI 1598729410

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	688	137
Omeprazole	Omeprazole	514	76
Atorvastatin Calcium	Atorvastatin Calcium	496	112
Triamcinolone Acetonide	Triamcinolone Acetonide	397	79
Gabapentin	Gabapentin	373	59
Metformin Hcl	Metformin Hcl	348	78
Albuterol Sulfate Hfa	Albuterol Sulfate	300	60
Ibuprofen	Ibuprofen	276	56
Losartan Potassium	Losartan Potassium	274	65
Naproxen	Naproxen	270	41
Celecoxib	Celecoxib	251	60
Baclofen	Baclofen	240	50
Trazodone Hcl	Trazodone Hcl	215	27
Furosemide	Furosemide	209	31
Benazepril Hcl	Benazepril Hcl	205	45
Carvedilol	Carvedilol	191	25
Hydrochlorothiazide	Hydrochlorothiazide	191	35
Ventolin Hfa	Albuterol Sulfate	180	31
Meclizine Hcl	Meclizine Hcl	172	40
Metoprolol Succinate	Metoprolol Succinate	154	30
Lisinopril	Lisinopril	148	28
Montelukast Sodium	Montelukast Sodium	128	20
Glipizide	Glipizide	125	31
Allopurinol	Allopurinol	123	17
Ofloxacin	Ofloxacin	123	45
Tamsulosin Hcl	Tamsulosin Hcl	120	23
Meloxicam	Meloxicam	114	17
Fluticasone Propionate	Fluticasone Propionate	111	23
Alendronate Sodium	Alendronate Sodium	107	19
Famotidine	Famotidine	107	18
Pantoprazole Sodium	Pantoprazole Sodium	106	28
Simvastatin	Simvastatin	101	22
Amoxicillin	Amoxicillin	100	62
Prednisone	Prednisone	99	39
Levothyroxine Sodium	Levothyroxine Sodium	94	17
Jardiance	Empagliflozin	90	22
Pravastatin Sodium	Pravastatin Sodium	84	19
Diclofenac Sodium	Diclofenac Sodium	82	22
Azithromycin	Azithromycin	77	55
Lovastatin	Lovastatin	76	16
Quetiapine Fumarate	Quetiapine Fumarate	76	12
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	73	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	66	14
Clopidogrel	Clopidogrel Bisulfate	65	15
Hydrocortisone	Hydrocortisone	64	16
Tradjenta	Linagliptin	59	11
Escitalopram Oxalate	Escitalopram Oxalate	58	suppressed
Eliquis	Apixaban	56	suppressed
Azelastine Hcl	Azelastine Hcl	55	14
Alprazolam	Alprazolam	54	suppressed
Fluocinonide	Fluocinonide	49	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	48	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	45	suppressed
Loperamide	Loperamide Hcl	43	22
Amitriptyline Hcl	Amitriptyline Hcl	42	suppressed
Nifedipine Er	Nifedipine	41	suppressed
Lorazepam	Lorazepam	38	suppressed
Breo Ellipta	Fluticasone/Vilanterol	37	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	37	suppressed
Potassium Chloride	Potassium Chloride	36	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	33	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	30	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	30	19
Dexlansoprazole Dr	Dexlansoprazole	29	suppressed
Ketoconazole	Ketoconazole	29	suppressed
Arnuity Ellipta	Fluticasone Furoate	28	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	27	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	27	11
Clonidine Hcl	Clonidine Hcl	26	suppressed
Cephalexin	Cephalexin	24	20
Megestrol Acetate	Megestrol Acetate	24	suppressed
Brilinta	Ticagrelor	23	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	23	17
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	23	suppressed
Farxiga	Dapagliflozin Propanediol	22	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	21	suppressed
Olanzapine	Olanzapine	21	suppressed
Amiodarone Hcl	Amiodarone Hcl	20	suppressed
Comfort Ez Pen Needle	Pen Needle, Diabetic	20	suppressed
Nitroglycerin	Nitroglycerin	20	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	19	suppressed
Buspirone Hcl	Buspirone Hcl	19	suppressed
Colchicine	Colchicine	19	suppressed
Finasteride	Finasteride	19	suppressed
Hydralazine Hcl	Hydralazine Hcl	19	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Risperidone	Risperidone	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Rivastigmine	Rivastigmine Tartrate	18	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	17	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	17	suppressed
Glimepiride	Glimepiride	17	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	16	suppressed
Donepezil Hcl	Donepezil Hcl	16	suppressed
Januvia	Sitagliptin Phosphate	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Prempro	Estrogen,con/M-Progest Acet	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	16	suppressed
Breyna	Budesonide/Formoterol Fumarate	15	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	14	suppressed
Cimetidine	Cimetidine	14	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Irbesartan	Irbesartan	14	suppressed
Linzess	Linaclotide	14	suppressed
Nystatin	Nystatin	14	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	14	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	14	suppressed
Tresiba Flextouch U-100	Insulin Degludec	14	suppressed
Valsartan	Valsartan	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Dulera	Mometasone/Formoterol	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Procto-Med Hc	Hydrocortisone	12	suppressed
Spironolactone	Spironolactone	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Pulmicort Flexhaler	Budesonide	11	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error